Dr. David M. Brizel

Claim this profile

Duke University Medical Center

Studies Oropharyngeal Cancer
Studies Oral Cancers
2 reported clinical trials
6 drugs studied

Area of expertise

1Oropharyngeal Cancer
David M. Brizel has run 2 trials for Oropharyngeal Cancer. Some of their research focus areas include:
Stage IV
PD-L1 positive
Stage I
2Oral Cancers
David M. Brizel has run 2 trials for Oral Cancers. Some of their research focus areas include:
Stage IV
PD-L1 positive
Stage I

Affiliated Hospitals

Image of trial facility.
Duke University Medical Center

Clinical Trials David M. Brizel is currently running

Image of trial facility.

Reduced Radiation Therapy

for Oropharyngeal Cancer

The purpose of this study is to use intra-treatment 18FDG-PET/CT during definitive radiation therapy for human papillomavirus (HPV)-related oropharyngeal cancer (OPC) as an imaging biomarker to identify and select patients with a favorable response for chemoradiation dose de-escalation. This study will prospectively evaluate the clinical outcomes for patients undergoing dose de-escalation.
Recruiting1 award N/A6 criteria

More about David M. Brizel

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments David M. Brizel has experience with
  • Elimusertib
  • Pembrolizumab
  • Stereotactic Body Radiation Therapy
  • 18 Fluorodeoxyglucose (FDG)-positron Emission Tomography (PET)-Computed Tomography (CT)
  • De-escalated Radiation Dose
  • Standard Radiation Dose
Breakdown of trials David M. Brizel has run
Oropharyngeal Cancer
Oral Cancers
Squamous Cell Carcinoma
Sinonasal Cancer
Oropharyngeal Carcinoma

Other Doctors you might be interested in

Ankoor ShahDuke University Medical Center
Georgia BeasleyDuke Cancer Center
Shelley Hwang, MDDuke University Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David M. Brizel specialize in?
David M. Brizel focuses on Oropharyngeal Cancer and Oral Cancers. In particular, much of their work with Oropharyngeal Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is David M. Brizel currently recruiting for clinical trials?
Yes, David M. Brizel is currently recruiting for 1 clinical trial in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that David M. Brizel has studied deeply?
Yes, David M. Brizel has studied treatments such as Elimusertib, Pembrolizumab, Stereotactic Body Radiation Therapy.
What is the best way to schedule an appointment with David M. Brizel?
Apply for one of the trials that David M. Brizel is conducting.
What is the office address of David M. Brizel?
The office of David M. Brizel is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top